SCHEMBL14005167

SCHEMBL14005167

COCCNC(=O)c1ccc(NNC(=O)c2cc3ccccc3[nH]2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.55
PIK3CA P42336 4/20 0.55
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
DRD2 P14416 1/20 0.53
DRD3 P35462 1/20 0.53
HTR2C P28335 1/20 0.52
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 2/20 0.51
HDAC3 O15379 2/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC2 Q92769 2/20 0.51
NCOR2 Q9Y618 1/20 0.51
HSD17B10 Q99714 1/20 0.50
AKR1C3 P42330 1/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HPGD P15428 1/20 0.49
HDAC4 P56524 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14005168 0.84 NPC1 (0.50) EGFRPIK3CANPC1RAB9ADRD2
SCHEMBL14005159 0.78 IDO1 (0.53) EGFRPIK3CANPC1RAB9AKDM4E
SCHEMBL22672938 0.76 NPC1 (0.57) EGFRPIK3CANPC1RAB9AKDM4E
SCHEMBL446419 0.73 KDM4E (0.56) NPC1RAB9ADRD2DRD3HTR2C
SCHEMBL3246963 0.73 KDM4E (0.68) NPC1RAB9ADRD2DRD3HTR2C
SCHEMBL24076391 0.73 KDM4E (0.65) DRD2DRD3HTR2CKDM4EALDH1A1
SCHEMBL30301403 0.73 KDM4E (0.65) DRD2DRD3HTR2CKDM4EALDH1A1
SCHEMBL13753861 0.72 DRD2 (0.84) DRD2DRD3HTR2CKDM4EALDH1A1
SCHEMBL13753661 0.72 KDM4E (0.72) EGFRPIK3CANPC1RAB9ADRD2
SCHEMBL16627663 0.72 SMYD3 (0.53) DRD2DRD3HTR2CKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809846-B2 Organic molecular memories and organic molecules for organic molecular memories KABUSHIKI KAISHA TOSHIBA (JP) 2014-08-19 US disclosed
US-20080293711-A1 Chemokine receptor modulators METASTATIX, INC. 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293711-A1 Chemokine receptor modulators CCR5, CCL2, CXCR4 EGFR 351/4885PIK3CA 1094/4885NPC1 363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.